A detailed history of Barclays PLC transactions in Codexis, Inc. stock. As of the latest transaction made, Barclays PLC holds 207,628 shares of CDXS stock, worth $1.06 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
207,628
Previous 207,628 -0.0%
Holding current value
$1.06 Million
Previous $640,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$2.62 - $3.71 $184,068 - $260,646
70,255 Added 51.14%
207,628 $640,000
Q2 2024

Aug 14, 2024

SELL
$2.65 - $3.92 $72,087 - $106,635
-27,203 Reduced 16.53%
137,373 $426,000
Q1 2024

May 15, 2024

SELL
$2.59 - $4.65 $131,704 - $236,457
-50,851 Reduced 23.6%
164,576 $575,000
Q4 2023

Feb 15, 2024

BUY
$1.54 - $3.37 $92,972 - $203,453
60,372 Added 38.94%
215,427 $657,000
Q3 2023

Nov 07, 2023

BUY
$1.5 - $3.75 $168,433 - $421,083
112,289 Added 262.57%
155,055 $294,000
Q2 2023

Aug 03, 2023

SELL
$2.21 - $4.43 $39,097 - $78,371
-17,691 Reduced 29.26%
42,766 $120,000
Q1 2023

May 04, 2023

BUY
$3.81 - $6.76 $89,401 - $158,623
23,465 Added 63.43%
60,457 $250,000
Q4 2022

Feb 13, 2023

BUY
$4.26 - $6.84 $36,648 - $58,844
8,603 Added 30.3%
36,992 $173,000
Q3 2022

Nov 03, 2022

BUY
$6.06 - $12.86 $45,813 - $97,221
7,560 Added 36.3%
28,389 $172,000
Q2 2022

Aug 12, 2022

SELL
$8.35 - $21.89 $70,114 - $183,810
-8,397 Reduced 28.73%
20,829 $218,000
Q1 2022

May 16, 2022

SELL
$16.97 - $31.93 $805,531 - $1.52 Million
-47,468 Reduced 61.89%
29,226 $604,000
Q4 2021

Feb 14, 2022

BUY
$25.61 - $41.78 $535,556 - $873,703
20,912 Added 37.49%
76,694 $2.4 Million
Q3 2021

Nov 09, 2021

BUY
$19.65 - $27.99 $663,403 - $944,970
33,761 Added 153.31%
55,782 $1.3 Million
Q2 2021

Aug 13, 2021

SELL
$17.48 - $25.46 $745,696 - $1.09 Million
-42,660 Reduced 65.95%
22,021 $499,000
Q1 2021

May 13, 2021

BUY
$18.08 - $28.8 $817,559 - $1.3 Million
45,219 Added 232.35%
64,681 $1.48 Million
Q4 2020

Feb 11, 2021

SELL
$11.7 - $23.41 $60,114 - $120,280
-5,138 Reduced 20.89%
19,462 $425,000
Q3 2020

Nov 12, 2020

SELL
$11.21 - $13.82 $54,839 - $67,607
-4,892 Reduced 16.59%
24,600 $289,000
Q2 2020

Aug 12, 2020

BUY
$9.8 - $12.77 $116,874 - $152,295
11,926 Added 67.89%
29,492 $336,000
Q1 2020

May 13, 2020

SELL
$8.78 - $18.6 $698,984 - $1.48 Million
-79,611 Reduced 81.92%
17,566 $196,000
Q4 2019

Feb 10, 2020

BUY
$13.12 - $17.06 $932,608 - $1.21 Million
71,083 Added 272.41%
97,177 $1.55 Million
Q3 2019

Nov 14, 2019

SELL
$12.75 - $19.01 $406,508 - $606,095
-31,883 Reduced 54.99%
26,094 $357,000
Q2 2019

Aug 14, 2019

BUY
$17.0 - $21.88 $202,147 - $260,175
11,891 Added 25.8%
57,977 $1.07 Million
Q1 2019

May 15, 2019

BUY
$15.53 - $22.15 $641,404 - $914,817
41,301 Added 863.13%
46,086 $946,000
Q4 2018

Feb 14, 2019

SELL
$14.06 - $22.57 $404,703 - $649,654
-28,784 Reduced 85.75%
4,785 $80,000
Q3 2018

Nov 14, 2018

BUY
$13.35 - $19.1 $377,991 - $540,797
28,314 Added 538.8%
33,569 $575,000
Q2 2018

Aug 14, 2018

SELL
$10.35 - $16.45 $37,767 - $60,026
-3,649 Reduced 40.98%
5,255 $75,000
Q1 2018

May 15, 2018

BUY
$8.0 - $12.8 $19,472 - $31,155
2,434 Added 37.62%
8,904 $98,000
Q4 2017

Feb 14, 2018

BUY
$5.85 - $8.4 $32,315 - $46,401
5,524 Added 583.93%
6,470 $54,000
Q3 2017

Nov 14, 2017

BUY
$4.9 - $6.65 $4,635 - $6,290
946
946 $6,000

Others Institutions Holding CDXS

About CODEXIS, INC.


  • Ticker CDXS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,494,100
  • Market Cap $335M
  • Description
  • Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...
More about CDXS
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.